• Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
    • Mergers & Acquisitions
  • Value-based Care
    • ACO

Syapse Leverages Machine Data Analytics to Safeguard Global Patient Data

by Jasmine Pennic 10/30/2019 Leave a Comment

Syapse_Syapse Forms Precision Medicine Council to Advance Precision Oncology Adoption

- Today, Syapse and Sumo Logic have released an announcement furthering the support and delivery of valuable real-world data-based insights to its health system and life sciences partners. - Sumo Logic’s standardized process, security and audit capabilities are helping Syapse through a global health system network, adhere to strict healthcare data regulations.Sumo Logic, the leader in continuous intelligence, today announced that Syapse has chosen Sumo Logic to support the delivery of valuable
Read More

Share with your friends










Submit

CB Insights Unveils ‘Digital Health 150’ List of Startups Transforming Healthcare

by Fred Pennic 10/02/2019 Leave a Comment

CB Insights Unveils ‘Digital Health 150’ List of Startups Transforming Healthcare

- CB Insights unveils first-ever annual ‘Digital Health 150’ list of digital health startups working to transform the healthcare industry. - The Digital Health 150 companies span a wide spectrum of categories that involve all three key stakeholder groups for the healthcare industry — providers, payers, and patients. - A total of 17 companies on the list are unicorns (private companies valued at $1B+). Of these, 12 companies are US-based, 3 are based in China, 1 is based in France, and 1
Read More

Share with your friends










Submit

FDA Cancer OCE, Syapse Partner on Regulatory Use of Real-World Evidence (RWE)

by Jasmine Pennic 08/14/2019 Leave a Comment

FDA Cancer COE, Syapse Partner on Regulatory Use of Real-World Evidence (RWE)

Syapse and the U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) have signed a multi-year Research Collaboration Agreement (RCA) focused on the use of real-world evidence (RWE) to support regulatory decision-making. Syapse and the OCE will work with stakeholders across the FDA to address key regulatory questions about testing and treatment patterns, dosing and safety, and outcomes in oncology, with a focus on precision medicine.Methods to Derive RWE From Multiple
Read More

Share with your friends










Submit

SHUH, Syapse to Build South Korea’s First Real-World Data Sharing Network for Precision Oncology Hospitals

by Jasmine Pennic 08/06/2019 Leave a Comment

SHUH, Syapse to Build South Korea’s First Real-World Data Sharing Network for Precision Oncology Hospitals

SNUH and Syapse will collaboratively work towards building South Korea’s first real-world data-sharing network for leading precision oncology hospitals in the region. Syapse, a company accelerating precision medicine through insights derived from its global health system network, and Seoul National University Hospital (SNUH), a South Korea-based hospital, today announced that they have extended their partnership with a new multi-year agreement. As part of their partnership, SNUH and Syapse will
Read More

Share with your friends










Submit

Pfizer, Syapse Partner on Oncology Precision Medicine Using Real-World Evidence (RWE)

by Jasmine Pennic 07/23/2019 Leave a Comment

Pfizer, Syapse Partner on Oncology Precision Medicine Using Real-World Evidence (RWE)

Syapse, a San Francisco, CA-based precision medicine company, today announced that it has entered into a strategic collaboration with Pfizer to advance cancer outcomes research using real-world evidence (RWE) toward the ultimate goal of improving patient health. This collaboration will initially focus on the molecular testing and therapy choices on precision oncology journeys in the healthcare system setting.Syapse NetworkThe Syapse Network enables health systems and their providers to learn
Read More

Share with your friends










Submit

Amgen, Syapse Partner to Develop Observational Research Analytics for Precision Oncology

by Fred Pennic 05/02/2019 Leave a Comment

Amgen, Syapse Partner to Develop Observational Research Analytics for Precision Oncology

 Amgen, a world leader in biotechnology, and Syapse, a company powering precision medicine insights through its global provider network, today announced a precision medicine collaboration in oncology. Under the terms of the collaboration, Amgen and Syapse will develop observational research analytics to assess treatment outcomes for areas of unmet need in oncology.Generates Insights from Real-World Evidence for Potential Use in Regulatory FilingsThis effort will identify existing patients within
Read More

Share with your friends










Submit

Syapse to Utilize NCCN Biomarkers Compendium for More Personalized Care

by Jasmine Pennic 11/01/2018 Leave a Comment

Google Cancer Research

New partnership between National Comprehensive Cancer Network and Syapse will augment health information technology around cancer care. The National Comprehensive Cancer Network(NCCN) announced a new agreement with Syapse, a precision medicine company, to expand the use of best practices in precision medicine when treating people with cancer. Syapse delivers solutions for scaling enterprise precision oncology programs. For Syapse, the data contained in theNCCN Biomarkers Compendium will
Read More

Share with your friends










Submit

Syapse Precision Medicine Council Launches to Advance Precision Oncology Adoption

by Fred Pennic 06/08/2018 Leave a Comment

Syapse_Syapse Forms Precision Medicine Council to Advance Precision Oncology Adoption

Syapse, a San Francisco, CA-based precision medicine company, announced today the formation of the Syapse Precision Medicine Council, a group of oncology, operations, and research leaders from health systems dedicated to advancing precision oncology adoption through sharing best practices.Inaugural members include Henry Ford Health System, Catholic Health Initiatives and Dignity Health (the Precision Medicine Alliance), Providence St. Joseph Health, Aurora Health Care, and the University of
Read More

Share with your friends










Submit

Medidata, Syapse Partner to Democratize Access to Oncology Clinical Trials

by Fred Pennic 02/01/2018 Leave a Comment

Syapse_Syapse Forms Precision Medicine Council to Advance Precision Oncology Adoption

Medidata, a provider of cloud-based technology and data analytics for clinical research, and Syapse, a precision medicine solutions provider, have announced a new partnership to transform oncology clinical trials for the age of precision medicine. As part of the new partnership, Medidata and Syapse will jointly develop a portfolio of solutions to make it easier for cancer patients to access potentially life-saving clinical trials,Partnership DetailsThe partnership will initially build products
Read More

Share with your friends










Submit

Syapse Expands Precision Medicine to Asia Through Partnership With Health System

by Fred Pennic 01/31/2018 Leave a Comment

Syapse_Syapse Forms Precision Medicine Council to Advance Precision Oncology Adoption

Syapse, a precision medicine company, announced today it is expanding to Asia through new partnerships with Seoul National University Hospital (SNUH), the premier hospital in Korea, and Megazone, a cloud-specialized IT company.Syapse and SNUH are launching a precision oncology program to improve cancer care in Korea, with the support of Megazone’s innovative cloud services. SNUH, one of the largest health systems in South Korea, is the first health system outside the U.S. to use the Syapse
Read More

Share with your friends










Submit
  • 1
  • 2
  • Next Page

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Read

  • Healthcare Breach Report 2016 6 Ways Health Informatics Is Transforming Health Care
  • CVS Health Launches Transform Oncology Care Program, Partners with Tempus CVS Health Launches Transform Oncology Care Program, Partners with Tempus
  • Why Interoperability Cannot Be Solved with Homogenous EHRs 5 Reasons Why A Single, Integrated EHR Will Not Solve Interoperability
  • Job Titles for Healthcare Executives The Top 9 Most In-Demand Medical Jobs
  • The State of Value-based Care in 2018: 10 Key Trends to Know The State of Value-based Care in 2018: 10 Key Trends to Know
  • Geographic Information Systems in Healthcare 5 Benefits of Geographic Information Systems in Healthcare
  • Clinical Operations Makes Highest Use of Artificial Intelligence, Tufts Study Finds 5 Ways Artificial Intelligence Is Transforming Digital Pathology
  • FDA Approves Blockchain/IoT Pilot to Track Specialty Prescription Drugs Across 3 States Blockchain in Healthcare_Next Stop for Data-driven Healthcare: Blockchain 5 Benefits Of Using Blockchain Technology in Healthcare
  • Express Scripts Launches First Digital Health Formulary for Apps & Devices Express Scripts Launches First Digital Health Formulary for Apps & Devices
  • 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2020 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2019. HIT Consultant Media. All Rights Reserved. Privacy Policy |